DiaSorin launch assay for identifying COVID-19 variants
Product News: DiaSorin releases assay for rapid identification of SARS-CoV-2 variants The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction 21 May 2021 DiaSorin has announced that it has released the Simplexa™ SARS-CoV-2 Variants Direct assay (RUO) to enable detection and discrimination of four SARS-CoV-2 mutations associated with circulating virus variants without requiring upfront RNA extraction. The assay helps to streamline and speed-up the pre-selection process of positive sam...
Source: selectscience.net